#Novo Nordisk

[ follow ]
#novo-nordisk
Entrepreneur
2 weeks ago
Wellness

Does Wegovy Work for Longterm Weight Loss? New Study Says Yes | Entrepreneur

Wegovy leads to 10% weight loss maintenance over four years for obesity patients without diabetes. [ more ]
Fast Company
4 weeks ago
Business

25,000 people begin taking Wegovy each week, but Novo Nordisk stock is sinking anyway

Novo Nordisk's significant increase in Wegovy users and sales shows a growing demand for weight loss drugs. [ more ]
London Business News | Londonlovesbusiness.com
1 month ago
Business

Novo Nordisk Q1 results: 'Strong performance' and 'rosy outlook' expected

Investment in Novo Nordisk's weight loss and diabetes drugs Wegovy and Ozempic led to record growth in Q4 2023. [ more ]
ABC7 San Francisco
1 month ago
Medicine

Sen. Bernie Sanders launches Senate investigation into 'high' pricing of Ozempic, Wegovy

Sen. Bernie Sanders investigating high drug prices for Ozempic and Wegovy. [ more ]
www.nytimes.com
1 month ago
Medicine

Senate Committee Investigates Ozempic and Wegovy Costs

The Senate Committee is investigating Novo Nordisk's high prices for Ozempic and Wegovy medications, urging the company to consider lowering costs for better accessibility. [ more ]
Entrepreneur
2 months ago
Wellness

Is Wegovy Covered By Insurance? These Insurers Offer Coverage | Entrepreneur

Major health insurance companies in the U.S. are starting to cover Novo Nordisk's weight loss injection Wegovy.
The FDA approved Wegovy for heart health after a study showed it could reduce the risk of heart attack and stroke by 20%. [ more ]
morenovo-nordisk
euronews
6 months ago
France politics

Five hundred new jobs coming in Chartres, south of Paris

Danish pharmaceutical giant Novo Nordisk is investing €2.1 billion in a French production site to expand the capacity and manufacturing of its anti-obesity drug.
Novo Nordisk's Semaglutide medication, originally meant for diabetes, is also effective against obesity and has massive global potential.
Goldman Sachs predicts that the global market for anti-obesity medication could reach $100 billion by 2030. [ more ]
[ Load more ]